Yubin I. Luo

Cancer Center And State Key Laboratory Of Biotherapy
Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 71 publications

Mechanism of CRM1 Inhibition by Lansoprazole and Its Synergy with Cisplatin in Gastric Cancer.

Mechanism of CRM1 Inhibition by Lansoprazole and Its Synergy with Cisplatin in Gastric Cancer.

Journal: Journal of medicinal chemistry

Published: May 14, 2026

Triphala ameliorates hyperuricemia-associated nephropathy by modulating the gut microbiota-glycerophospholipid-TLR4 axis.

Triphala ameliorates hyperuricemia-associated nephropathy by modulating the gut microbiota-glycerophospholipid-TLR4 axis.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: April 08, 2026

HLA-B27-associated gut microbiota and amino acid perturbations promote ankylosing spondylitis through M1 macrophage activation.

HLA-B27-associated gut microbiota and amino acid perturbations promote ankylosing spondylitis through M1 macrophage activation.

Journal: Gut microbes

Published: February 16, 2026

UPLC-MS/MS-based metabolomics analysis identifies disease-associated metabolic signatures of B cells from patients with IgG4-RD.

UPLC-MS/MS-based metabolomics analysis identifies disease-associated metabolic signatures of B cells from patients with IgG4-RD.

Journal: Frontiers in immunology

Published: December 30, 2025

Reply: "Toward a more translational SS-ILD model: Sex differences, endpoints, and B cell targets".

Reply: "Toward a more translational SS-ILD model: Sex differences, endpoints, and B cell targets".

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: December 11, 2025

Correction: Neutrophils as key drivers of pulmonary fibrosis: unveiling mechanisms and therapeutic implications.

Correction: Neutrophils as key drivers of pulmonary fibrosis: unveiling mechanisms and therapeutic implications.

Journal: Frontiers in immunology

Published: December 05, 2025

Mesenchymal stem cell-derived microvesicles confer protection against rheumatoid arthritis-associated interstitial lung disease.

Mesenchymal stem cell-derived microvesicles confer protection against rheumatoid arthritis-associated interstitial lung disease.

Journal: Stem cell research & therapy

Published: December 02, 2025

Quantitative comparative analysis of different CT modalities in systemic sclerosis-associated interstitial lung disease: correlations with lung function, serological biomarkers, and disease stratification.

Quantitative comparative analysis of different CT modalities in systemic sclerosis-associated interstitial lung disease: correlations with lung function, serological biomarkers, and disease stratification.

Journal: Journal of thoracic disease

Published: November 05, 2025

Bilirubin regulating the onset of rheumatoid arthritis.

Bilirubin regulating the onset of rheumatoid arthritis.

Journal: Annals of the rheumatic diseases

Published: October 31, 2025

Neutrophils as key drivers of pulmonary fibrosis: unveiling mechanisms and therapeutic implications.

Neutrophils as key drivers of pulmonary fibrosis: unveiling mechanisms and therapeutic implications.

Journal: Frontiers in immunology

Published: October 03, 2025

Repurposing simeprevir uncovers a druggable KPNB1-p65-BCL2 survival axis in cancer.

Repurposing simeprevir uncovers a druggable KPNB1-p65-BCL2 survival axis in cancer.

Journal: Cell chemical biology

Published: September 29, 2025

IgG subclass-specific N-glycosylation differentiates HRCT subtypes in idiopathic inflammatory myopathies-associated ILD.

IgG subclass-specific N-glycosylation differentiates HRCT subtypes in idiopathic inflammatory myopathies-associated ILD.

Journal: Frontiers in immunology

Published: August 31, 2025

Showing 1-12 of 71

Last Updated: 09/26/2026